Analytical Data
-
基因名
SH3BGRL2
- Application
-
别名
SH3BGRL2;FASH3;SH3 domain-binding glutamic acid-rich-like Protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UJC5
-
表达区间
1-107aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSMVIRVFI ASSSGFVAIK KKQQDVVRFL EANKIEFEEV DITMSEEQRQ WMYKNVPPEK KPTQGNPLPP QIFNGDRYCG DYDSFFESKE SNTVFSFLGL KPRLASKAEP
-
分子量
15 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SH3BGRL2 (SH3 domain binding glutamate-rich protein-like 2) is a protein that has garnered attention in recent years due to its potential roles in cellular signaling and disease mechanisms. As a member of the SH3 domain-containing protein family, SH3BGRL2 is involved in various biological processes, including cell growth, differentiation, and apoptosis. Its expression is regulated in response to various stimuli, suggesting that it may play a pivotal role in cellular response to stress and signaling pathways. Research has indicated that SH3BGRL2 may be implicated in several diseases, including cancer and neurodegenerative disorders, due to its impact on cell proliferation and survival. The study of SH3BGRL2 recombinant protein is crucial for elucidating its function and interactions at the molecular level, providing insights into its involvement in relevant biological processes and potential therapeutic targets. Moreover, understanding its structure and function could lead to the development of novel strategies for diagnosing and treating conditions related to dysfunctional SH3BGRL2 activity. Thus, research on SH3BGRL2 recombinant protein not only advances our knowledge of fundamental cellular mechanisms but also opens avenues for innovative medical applications.
